FDA Generative AI Medical Device Evidence Matrix
A 2026 analyst guide to FDA's GenAI medical device discussion paper, with a two-axis risk matrix, competency evidence plan, lifecycle monitoring controls, and 30/60/90-day readiness actions.
Back to Articles
Articles tagged with “lifecycle-monitoring”